Joseph Schoepfer

CHAPTER 8:Discovery of NVP-AUY922

Paul Brough, Joseph Schoepfer, Andrew Massey, 2013 .

On the use of three dimensional structural information in the design of potent and selective antagonists of the SH2 domain of Grb2

Joseph Schoepfer, Pascal Furet, C. Garcia Echeverria, 1999 .

Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue

Joseph Schoepfer, Pascal Furet, R. Schmitz, 2009, BMC Chemical Biology.

A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients.

Joseph Schoepfer, Clive McCarthy, Pascal Furet, 2011, Cancer research.

NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models

Joseph Schoepfer, Michael Rugaard Jensen, Robert Cozens, 2008, Breast Cancer Research.

Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes

Joseph Schoepfer, Joerg Kallen, Pascal Furet, 2019, ChemMedChem.

The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

Hans Bitter, Franco Lombardo, Joseph Schoepfer, 2017, Nature.